Investigational device, not for sale in the USA
The EndoWays system is designed to:
The EndoWays system is currently undergoing animal studies and will be marketed for interventional radiology procedures such as liver embolization, BPH, neuroradiology and more.
The total addressable market for vascular interventions in the U.S. exceeds $2 billion.
Seasoned entrepreneur with over twenty years of experience in the field of minimally invasive vascular interventions
Experienced R&D engineer in the medical device industry, specializing in catheter development